Background and objective. Immunohistological studies on salivary and lacrimal glands have yielded conflicting results on the Th1/Th2 balance in primary Sjögren´s syndrome (pSS). The aim of this study was to establish whether pSS is a Th1 or Th2 directed autoimmune disease by analysing the polymorphism of the genes encoding for cytokines involved in the regulation of Th1/Th2 differentiation.
Introduction
Primary Sjögren´s syndrome (pSS) is a chronic autoimmune exocrinopathy presenting clinically with dry eyes and mouth and various extraglandular symptoms. Hypergammaglobulinemia and autoantibody production are characteristic features of the disease. Histologically lymphocyte and plasma cell infiltration in the affected organs is observed. T-cell-mediated autoimmune responses are currently considered to be key factors in organ destruction in SS [1] .
CD4 helper T (Th) cells differentiate into Th1 and Th2 cells, of which the former are primarily responsible for the development of cell-mediated immunity and Th2 cells are involved in antibody production and humoral immune responses. Cytokines direct the immune responses toward a Th1 or Th2 type. Interleukin-4 (IL-4) and IL-13 are key mediators in the Th2 pathway, while interferon gamma (IFN-γ), IL-2, IL-12 and IL-18 act as Th1 cytokines. Organ-specific autoimmune diseases such as rheumatoid arthritis and diabetes are Th1-mediated, whereas asthma and atopic diseases are examples of classical Th2 diseases [for reviews, see [2] [3] .
In pSS the data concerning Th1/Th2 differentiation are somewhat conflicting. Although the greater part of the evidence on the cytokines expressed in labial salivary gland tissue samples supports the view that pSS is a Th1-mediated disease [4] [5] [6] [7] [8] [9] , studies questioning the predominance of a Th1 response in SS have also been reported [9] [10] . Also, Th2 dominance has been shown in lacrimal autoimmune disease in SS, albeit only in mouse models [11] [12] .
To elucidate the issue of whether the Th1 or the Th2 responses play the main role in pSS, we decided to study the polymorphisms of the genes encoding cytokines involved in the regulation of Th1/Th2 differentiation. We examined in a well-characterised group of Finnish Caucasian patients with pSS the polymorphisms of the genes encoding the cytokines regulating the Th1/Th2 balance (IL4-590 C/T in the promoter region, IL13+2044 G/A in the coding region and interferon-γ [IFNG] +874 T/A in the promoter region). We chose particularly genes which have been shown to be associated with Th1/Th2 differentiation (IL4 and IL13 towards Th2 and IFNG towards Th1 differentiation) in several studies and are known to be functional, influencing either the serum levels of the corresponding cytokine or the transcriptional activity of the gene [13] [14] [15] [16] . Of these, the allele T of the IL4 -590 gene has been shown to be associated with increased production of IL-4 [13] , the allele A of the IL13+2044 gene results in the replacement of the amino acid arginine to glutamine at position 130, which may affect the function of the IL-13 protein [14] and the allele T of IFNG +874 is associated with high production of IFN γ [15] [16] .
Subjects and methods

Subjects
All patients fulfilling three or more modified Californian criteria for primary Sjögren's syndrome [17] (salivary flow determinations were not performed, histological findings were graded on the Chisholm-Mason scale [18] , grades 3 and 4 being regarded as diagnostic) were selected from the records of patients with sicca symptoms examined in the Department of Internal Medicine, Section of Rheumatology, at Tampere University Hospital, Finland, during the years 1977 to 1992 (n = 111). Those alive were invited by letter to attend for gene polymorphism determinations and samples for genotyping were obtained after informed consent from 63 pSS patients (61 female, 2 male, mean age 60 ± 12 years, range 29-82 years). The mean disease duration was 9 ± 4 years (range, 3-18 years). Sixty-one of the subjects also fulfilled the revised American-European consensus group criteria for pSS [19] .
Clinical methods
A careful clinical examination together with an in-depth interview with the patients covering previous and concurrent diseases, previous and current medications and duration of pSS had recently been conducted with these patients [20] . Special emphasis was laid on possible extraglandular symptoms of pSS (dermatological, endocrine, gastrointestinal, lymphoproliferative, musculoskeletal, neurological, renal, respiratory and vascular symptoms). Purpura was defined as a history of typical episodic palpable purpura lesions in the lower limbs or skin biopsy histology. Lymphadenopathy was defined as lymph node enlargement so persistent as to have indicated a nodal biopsy. Arthritis was defined as articular swelling observed by a clinician. Peripheral and central neurological symptoms were recorded from the history given by the patients as well as from data on possible neurological investigations from the case histories. The diagnosis of pulmonary fibrosis was based on findings in chest radiographs; the diagnosis of alveolitis had been established by thorough investigations in a pulmonary unit. The presence of distal renal tubular acidosis (dRTA) had been checked for by ammonium chloride loading tests in 45 of the patients and urinary total protein excretions had been measured in 61 [20] .
Normal controls
Sixty-three healthy Finnish Red Cross Transfusion Service blood donors matched for sex (61 female, 2 male), ethnic origin (Finnish Caucasian) and area of residence (Tampere, Finland) served as a control group for DNA studies of pSS patients. The mean age of the control subjects was 53 ± 7 years.
Standard laboratory tests
The standard laboratory tests included erythrocyte sedimentation rate (ESR) and serum concentrations of immunoglobulins IgA, IgG and IgM. Rheumatoid factor (RF) was determined by laser nephelometry and antinuclear antibodies (ANA) by indirect immunofluorescence using Hep-2 cells. Anti-SS-A and anti-SS-B antibodies were determined by enzyme immunoassay. Serum complement levels (C3 and C4), were measured by laser nephelometry. Serum beta-2 microglobulin was measured by radioimmunoassay (Pharmacia beta-2-micro RIA kit, Pharmacia Diagnostics Uppsala, Sweden).
Genotyping DNA specimens from whole-blood samples were prepared using standard methods. To analyse the base exchange polymorphism at -590 of the IL4 gene (C to T base exchange) the region containing the AvaII polymorphic site at position -590 of the IL4 gene was amplified by PCR [21] . The oligonucleotides 5´TAA ACT TGG GAG AAC ATG GT 3´and 5´TGG GGA AAG ATA GAG TAA TA 3´ were used as primers. Fragments were analysed by electrophoresis on 3% agarose stained with ethidium bromide.
Genotyping of the IL13 polymorphism at position +2044 (G/A) was performed using the ABI PRISM 7000 Sequence Detection System for both PCR and allelic discrimination (Applied Biosystems, CA, USA). A commercial kit from Applied Biosystems was used (Assay on Demand, Purchase number 185118655)
The base exchange polymorphism at +874 of the IFNG gene (T/A) was analysed by the amplification refractory mutational system-polymerase chain reaction method (ARMS-PCR) described previously [15] . Genomic DNA was amplified with Thermoprime PLUS DNA polymerase (Abgene, Surrey, UK) in two different PCR reactions; each reaction employed a generic antisense primer 5'-TCAACAAAGCTGATACTCCA-3' and one of the two allele-specific sense primers 5'-TTCTTACAACACAAAATCAAATCT-3'. To confirm the success of PCR amplification, one internal control of 426 bp was amplified using a pair of primers designed from the nucleotide sequence of the human growth hormone (5'-CCTTCCCAACCATTCCCTTA-3' and 5'-TCACGGATTTCTGTTGTGTTTC-3'). The amplified products were separated by electrophoresis on a 2 % agarose gel stained with ethidium bromide. All genotype distributions studied followed the Hardy-Weinberg equilibrium.
Statistical analysis
Unpaired Student´s t test and Chi-square test were used in comparisons of continuous and dichotomous variables, respectively. Findings were considered statistically significant at p < 0.05. Statistical analyses were performed with SPSS 10.1 for Windows.
Ethical approval
The study protocol was approved by the Ethical Committee of Tampere University Hospital and by the Ethical Committee of the Finnish Red Cross Transfusion Service, Helsinki, Finland. 
IL4-590 gene polymorphism
The level of blood ESR was lower in pSS patients with the IL4-590 T allele compared with those without. The frequencies of positive results for RF, ANA or anti-SSA-or anti-SSB antibodies did not differ between pSS patients carrying the IL4-590 T allele and those not carrying this determinant. There were no differences in the levels of serum immunoglobulins IgG or IgM between the patient groups. Serum IgA concentration was significantly lower (p=0.049) and serum beta-2 microglobulin concentration tended to be lower (p=0.063) in pSS patients carrying the IL4-590 T allele compared with non-carriers ( Table 3) . Purpura occurred in only 11 % of the pSS patients carrying the IL4-590 allele T vs. 31% of noncarriers, p=0.047. No differences were observed in the frequencies of salivary gland swelling or such extraglandular manifestations of pSS as a history of arthralgia, arthritis, Raynaud´s symptom, lymphadenopathy, pleuritis, alveolitis or pulmonary fibrosis, peripheral or central nervous system symptoms, presence of overt dRTA. However, when the pSS patients were grouped by the total amount of extraglandular manifestations present into those with 0-2 and those with more than 2, the pSS patients carrying the IL4-590 T allele had significantly fewer extraglandular manifestations than those not carrying this allele (table 3) . The histological grade in labial salivary gland biopsies or the number of diagnostic criteria for pSS did not differ in patients with or without IL4 -590 T allele. There were no significant differences in the previous use of disease modifying antirheumatic drugs or corticosteroids between the groups. .The frequencies of associated diseases such as hypothyroidism and celiac disease did not differ between the patient groups (data not shown).
IL13+2044 gene polymorphism
The patients carrying the IL13+2044 allele A had significantly lower levels of ESR and serum beta-2 microglobulin compared with those not carrying this allele (Table 3) . Purpura occurred in only 9 % of the pSS patients carrying the IL13 allele A vs. 38% of non-carriers, p=0.007.
Carriers of IL4-590 T allele and IL13+2044 A allele
The IL13+2044A and the IL4-590 loci are known to be in strong linkage disequilibrium [31] . In our material, 80 % of the pSS patients carrying the IL13+2044 A allele carried the IL4-590 T allele compared with 29% of non-carriers, p < 0.0001.
The laboratory findings in the pSS patients carrying both the IL4-590 T and the IL13+2044 A allele are presented in Table 4 . Purpura occurred in only 14 % of the pSS patients carrying the IL4 allele T and IL13 allele A (n=28) vs. 35% of the corresponding non-carriers (n=17), p=0.004. They also had a lower total amount of extraglandular manifestations present than those not carrying these alleles (table 4) . Table 4 
IFNG+874 gene polymorphism
There were no statistically significant differences in any of the laboratory parameters or the clinical features described above between pSS patients with the IFNG+874 allele T compared with those without (data not shown).
Discussion
The data concerning the Th1/Th2 balance in pSS patients are somewhat conflicting. Both Th1 and Th2 cytokine levels have been found to be elevated in the peripheral blood of pSS patients as compared to normal subjects [22] . On the other hand, a decreased ratio of peripheral blood Th1/Th2-producing cells has been reported in pSS patients [23] [24] . In normal subjects it has been shown that the lymphocytes infiltrating the labial salivary glands evince a potential to produce both Th1 and Th2 cytokines [6] . In the majority of studies on patients with pSS the expression of Th1 cytokines has dominated in labial salivary gland biopsies and tissue samples have totally lacked the expression of Th2 cytokines IL-4 and IL-13 [4] [5] [6] [7] [8] [9] . However, in two studies IL-4 expression in some and IL-13 expression in the majority of SS salivary gland biopsies were also found, arguing against the predominance of a Th1 response in SS [9] [10] .
Instead of studying levels of Th1 and Th2 cytokines in peripheral blood, we chose here another approach, i.e. we investigated the genetics of cytokines which have previously been shown to be associated with Th1/Th2 differentiation in several studies and are known to be functional [13] [14] [15] [16] . We found that neither the allele or genotype frequencies of classical Th2 cytokines (IL4 and IL13) nor the Th1 cytokine (IFNG) were different in patients with pSS as against healthy control subjects. Hence, we did not establish firm and conclusive evidence for a clear Th1 or Th2 predilection in pSS. Previously, an association of IL10 genetics with a predisposition to pSS has been observed, the GCC haplotype (G at position -1082, C at -819, and C at -592) being associated with increased risk for pSS [25] [26] and higher plasma IL-10 concentrations [25] . IL-10 is a cytokine known to modulate both Th1 and Th2 activities in man and to induce both antiinflammatory and proinflammatory responses. IL-10 produced by regulatory T cells suppresses the effector immune responses [3] and as it was the high IL-10 -producer genotype which was found to be increased in patients with pSS [25] , the IL-10 dependent regulatory function is probably more potent in them.
The genes encoding IL-4 and IL-13 are known to be associated with the Th2-mediated diseases asthma and atopy, as well as with IgE production [14, 27] . Within the group of patients with pSS the genetics of IL4 and IL13 was in the present study associated with laboratory parameters indicative of a mild disease (e.g. low ESR and IgA concentrations) and seemed to protect from the extraglandular manifestation of purpura. As the presence of purpura has been found an adverse predictor for development of lymphoma in pSS [28] , this finding further indicates that Th2 genotypes are associated with a milder form of pSS. Furthermore, the concentration of serum beta-2 microglobulin, known to reflect activation of the lymphopoetic system and to be increased in lymphoproliferative complications of pSS [29] [30] , was found to be lower in carriers of the more rare genotypes of IL4 and IL13. The IL4-590 and IL13+2044 genotypes are known to be in strong linkage disequilibrium [31] and were also here significantly associated with each other. When grouping together the pSS patients carrying the more rare alleles IL4-590 T and IL13+2044 A and comparing them with a subgroup not carrying either of these alleles it was noted that the observed effects were even stronger. As features of a milder pSS were significantly associated with genotypes which contribute to a Th2 disease, one might postulate that pSS would be a predominantly Th1-dominated disease. A shift towards Th2 differentiation seems at least clearly to elicit features of milder pSS. Similarly, the rare allele of IL4 VNTR, which is known to be increased in atopic diseases, has been found to be associated with less severe disease in rheumatoid arthritis, a clearly established Th1 disease [32] . However, we observed no association with the polymorphisms of the Th1 cytokine IFNG and the severity of pSS.
To conclude, the frequencies of cytokine genes regulating the Th1/Th2 differentiation did not differ between pSS patients and healthy control subjects. However, the presence of cytokine genes with increased susceptibility to Th2 diseases was associated with signs of a milder form of pSS, as in rheumatoid arthritis, a classical Th1 disease. This finding would favour the hypothesis envisaging pSS as a primarily Th1-mediated autoimmune disease, but these findings should be confirmed in independent cohorts of pSS patients.
